Burning Rock Biotech
17 hedge funds and large institutions have $4.57M invested in Burning Rock Biotech in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 2 closing their positions.
13.42% more ownership
Funds ownership: 2.59% → 16% (+13%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
6% less funds holding
Funds holding: 18 → 17 (-1)
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
53% less capital invested
Capital invested by funds: $9.65M → $4.57M (-$5.08M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$75.9K |
| 2 |
Morgan Stanley
New York
|
+$23.2K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$1.86K |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
+$310 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity International
Hamilton,
Bermuda
|
-$1.18M |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$1.05M |
| 3 |
Millennium Management
New York
|
-$591K |
| 4 |
CL
CRCM LP
San Francisco,
California
|
-$97.8K |
| 5 |
JP Morgan Chase
New York
|
-$214 |
BNR Hedge Fund Activity: Q2 2025 in Review
17 of the 7,598 institutional investors tracked by Wall St. Rank reported a position in Burning Rock Biotech (BNR) for Q2 2025, worth a combined $4.57M — down 53% from $9.65M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of BNR and 1 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 3 added.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $75.9K. The largest seller was Fidelity International, exiting entirely with an estimated $1.18M sold.
- 17 institutional investors held Burning Rock Biotech (BNR) as of Q2 2025, down from 18 in Q1 2025.
- Funds reported $4.57M of Burning Rock Biotech stock for Q2 2025, down 53% quarter-over-quarter.
- 1 fund opened new Burning Rock Biotech positions in Q2 2025 and 2 closed out, a net change of -1 holder.
- The largest Burning Rock Biotech buyer in Q2 2025 was Citadel Advisors, an estimated $75.9K added.
- The largest Burning Rock Biotech seller in Q2 2025 was Fidelity International, an estimated $1.18M sold.
Based on aggregated 13F filings for Q2 2025.